Percentage of prostate-specific antigen reduction is a useful tool to assess men following focal therapy for localised prostate cancer.
The Role of Percentage of Prostate-specific Antigen Reduction After Focal Therapy Using High-intensity Focused Ultrasound for Primary Localised Prostate Cancer. Results from a Large Multi-institutional Series
Stabile A.;Montorsi F.;Briganti A.;
2020-01-01
Abstract
Percentage of prostate-specific antigen reduction is a useful tool to assess men following focal therapy for localised prostate cancer.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
